Table 2.
Patient demographics and clinicpathological characteristics
| NACRT (n = 17) | Non-NACRT (n = 11) | P-value | |
|---|---|---|---|
| Age(mean ± SD) | 59.9 ± 7.9 | 63.6 ± 10.4 | 0.287*1 |
| Gender(male/female) | 8/9 | 6/5 | 1.000*2 |
| Operative procedures PD/DP/TP | 13/3/1 | 10/1/0 | 1.000*2 |
| Portal vein resection | 70.6% (12/17) | 63.6% (7/11) | 1.000*2 |
| cT(1/2/3/4) | 0/0/17/0 | 0/0/11/0 | 1.000*2 |
| cN(0/1) | 11/6 | 6/5 | 0.701*2 |
| pT(0/1/2/3/4) | 0/1/16/0 | 0/0/11/0 | 1.000*2 |
| pN(0/1) | 13/4 | 5/6 | 0.125*2 |
| Histological classification G1-2/G3/ungradeable | 11/5/1 | 8/3/0 | 1.000*2 |
| Residual tumor R0/R1-2 | 17/0 | 9/2 | 0.146*2 |
| Tumor destruction (Evan’s criteria)I/IIa/IIb/III/IV | 1/7/7/2/0 |
SD: standard deviation; PD: pancreatoducdenectomy; DP: distal pancreatectomy; TP total pancreatectomy. *1: Unpaired t-test. *2: Fisher’s exact test.